US health regulators make it easier to approve new ways to identify germs

US health regulators are classifying a new type of lab equipment, called a clinical mass spectrometry microorganism identification and differentiation system, into a lower-risk category. This means manufacturers will face fewer hurdles to get these devices approved and into hospitals.

For years, getting new medical devices approved in the US has been a slow and expensive process, especially for innovative technologies. This change means that a specific type of advanced diagnostic tool can now reach patients faster. It signals a shift towards streamlining approval for technologies that regulators deem safe and effective, potentially speeding up access to new diagnostic methods.